105 related articles for article (PubMed ID: 2117550)
1. The sequence of the hemoregulatory peptide is present in Gi alpha proteins.
Laerum OD; Frostad S; Tøn HI; Kamp D
FEBS Lett; 1990 Aug; 269(1):11-4. PubMed ID: 2117550
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
Pfeilstöcker M; Karlic H; Paukovits J; Anzenberger G; Louda N; Salamon J; Mühlberger H; Strobl H; Pittermann E; Heinz R
Leukemia; 1999 Apr; 13(4):590-4. PubMed ID: 10214866
[TBL] [Abstract][Full Text] [Related]
3. Effects of a hemoregulatory peptide (HP5b) on erythroid and myelopoietic colony formation in vitro.
Kreja L; Hågå P; Muller-Bérat N; Laerum OD; Sletvold O; Paukovits WR
Scand J Haematol; 1986 Aug; 37(2):79-86. PubMed ID: 3764340
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.
Alisauskas RM; Goldenberg DM; Sharkey RM; Blumenthal RD
Int J Cancer; 1997 Jan; 70(3):323-9. PubMed ID: 9033635
[TBL] [Abstract][Full Text] [Related]
5. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro.
Laerum OD; Sletvold O; Bjerknes R; Eriksen JA; Johansen JH; Schanche JS; Tveterås T; Paukovits WR
Exp Hematol; 1988 May; 16(4):274-80. PubMed ID: 3258825
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
Paukovits WR; Moser MH; Rutter R; Paukovits JB
Ann N Y Acad Sci; 1991; 628():92-104. PubMed ID: 2069326
[No Abstract] [Full Text] [Related]
7. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of hemoregulatory peptide (HP5b) action in culture.
Laerum OD; Aakvaag A; Frostad S; Kalland T; Langen P; Maurer HR
Int J Cell Cloning; 1990 Nov; 8(6):431-44. PubMed ID: 2273297
[TBL] [Abstract][Full Text] [Related]
9. A synthetic hemoregulatory peptide (HP5B) inhibits human myelopoietic colony formation (CFU-GM) but not leukocyte phagocytosis in vitro.
Laerum OD; Sletvod O; Bjerknes R; Paukovits WR
Eur J Haematol; 1987 Sep; 39(3):259-66. PubMed ID: 3678477
[TBL] [Abstract][Full Text] [Related]
10. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
Paukovits WR; Hergl A; Schulte-Hermann R
Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
[TBL] [Abstract][Full Text] [Related]
11. Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
Frostad S; Kalland T; Aakvaag A; Laerum OD
Stem Cells; 1993 Jul; 11(4):303-11. PubMed ID: 8401253
[TBL] [Abstract][Full Text] [Related]
12. Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.
Veiby OP; Løvhaug D; Fjerdingstad H; Engelsen SJ
Exp Hematol; 1992 Feb; 20(2):192-5. PubMed ID: 1544388
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.
Veiby OP; LoCastro S; Bhatnagar P; Olsen WM
Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541
[TBL] [Abstract][Full Text] [Related]
14. [A granulopoiesis inhibitor. Synthesis and biological activity].
Kulikov SV; Leonova EB; Kalinina NM; Samartsev MA; Bubnova LN; Glazanova TV; Pavlova IE; Ketlinskiĭ SA
Bioorg Khim; 1995 Jun; 21(6):421-9. PubMed ID: 7661866
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory peptides in hematopoiesis.
Guigon M; Bonnet D
Exp Hematol; 1995 Jun; 23(6):477-81. PubMed ID: 7768302
[TBL] [Abstract][Full Text] [Related]
16. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
17. Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
Paukovits WR; Moser MH; Binder KA; Paukovits JB
Blood; 1991 Mar; 77(6):1313-9. PubMed ID: 2001454
[TBL] [Abstract][Full Text] [Related]
18. Modulation of murine hemopoiesis in vivo by a synthetic hemoregulatory pentapeptide (HP 5b).
Laerum OD; Paukovits WR
Differentiation; 1984; 27(2):106-12. PubMed ID: 6548197
[TBL] [Abstract][Full Text] [Related]
19. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
[TBL] [Abstract][Full Text] [Related]
20. Modification of mouse hemopoietic cell proliferation in vivo by a hemoregulatory pentapeptide (HP 5b). Relation to circadian rhythms.
Laerum OD; Paukovits WR
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(4):333-48. PubMed ID: 6150578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
